Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Other Non-Current Assets: 2009-2025

Historic Other Non-Current Assets for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to $6.6 million.

  • Lifecore Biomedical's Other Non-Current Assets rose 15.79% to $6.6 million in Q2 2025 from the same period last year, while for May 2025 it was $6.6 million, marking a year-over-year increase of 15.79%. This contributed to the annual value of $6.6 million for FY2025, which is 15.79% up from last year.
  • Lifecore Biomedical's Other Non-Current Assets amounted to $6.6 million in Q2 2025, which was up 33.02% from $4.9 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical's Other Non-Current Assets registered a high of $170.4 million during Q1 2021, and its lowest value of $2.6 million during Q4 2024.
  • In the last 3 years, Lifecore Biomedical's Other Non-Current Assets had a median value of $4.2 million in 2023 and averaged $4.4 million.
  • As far as peak fluctuations go, Lifecore Biomedical's Other Non-Current Assets soared by 8,320.60% in 2021, and later plummeted by 92.58% in 2023.
  • Lifecore Biomedical's Other Non-Current Assets (Quarterly) stood at $133.2 million in 2021, then tumbled by 65.78% to $45.6 million in 2022, then plummeted by 91.07% to $4.1 million in 2023, then plummeted by 36.96% to $2.6 million in 2024, then increased by 15.79% to $6.6 million in 2025.
  • Its Other Non-Current Assets was $6.6 million in Q2 2025, compared to $4.9 million in Q1 2025 and $2.6 million in Q4 2024.